![Fa Hong Xu](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Fa Hong Xu
Director Ejecutivo en Jiangxi ZSM Pharmaceutical Co., Ltd. .
Cargos activos de Fa Hong Xu
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Jiangxi ZSM Pharmaceutical Co., Ltd.
![]() Jiangxi ZSM Pharmaceutical Co., Ltd. Medical DistributorsDistribution Services Jiangxi ZSM Pharmaceutical Co., Ltd. is a large-scale eye care enterprise based in Fuzhou, China. The Chinese company specializes in eye drops and is known for its brand Zhenshiming, which offers a range of eye drops for various eye conditions such as eye fatigue, myopia, dry eye syndrome, redness, cataracts, and infections. Zhenshiming eye drops are also known for their ability to protect eyes from screen damage and relieve eye fatigue. The company was founded in 2006, and the CEO is Fa Hong Xu. Jiangxi ZSM Pharmaceutical Co. was acquired by Jiangxi ZSM Pharmaceutical Co. Ltd. /Pvt Grp/ on December 16, 2021 for $263.82 million. | Director/Miembro de la Junta | - | - |
Director Ejecutivo | - | - |
Historial de carrera de Fa Hong Xu
Estadísticas
Internacional
China | 2 |
Operativa
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Sectorial
Distribution Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 1 |
---|---|
Jiangxi ZSM Pharmaceutical Co., Ltd.
![]() Jiangxi ZSM Pharmaceutical Co., Ltd. Medical DistributorsDistribution Services Jiangxi ZSM Pharmaceutical Co., Ltd. is a large-scale eye care enterprise based in Fuzhou, China. The Chinese company specializes in eye drops and is known for its brand Zhenshiming, which offers a range of eye drops for various eye conditions such as eye fatigue, myopia, dry eye syndrome, redness, cataracts, and infections. Zhenshiming eye drops are also known for their ability to protect eyes from screen damage and relieve eye fatigue. The company was founded in 2006, and the CEO is Fa Hong Xu. Jiangxi ZSM Pharmaceutical Co. was acquired by Jiangxi ZSM Pharmaceutical Co. Ltd. /Pvt Grp/ on December 16, 2021 for $263.82 million. | Distribution Services |
- Bolsa de valores
- Insiders
- Fa Hong Xu
- Experiencia